Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration – a positron emission tomography study

@article{Kanerva1999Brain5R,
  title={Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration – a positron emission tomography study},
  author={H. Kanerva and H. Vilkman and K. N{\aa}gren and O. Kilkku and M. Kuoppam{\"a}ki and E. Syv{\"a}lahti and J. Hietala},
  journal={Psychopharmacology},
  year={1999},
  volume={145},
  pages={76-81}
}
Rationale: Deramciclane fumarate is a new 5-HT2A and 5-HT2C receptor antagonist with putative anxiolytic effects. In the present study the binding of deramciclane to serotonin 5-HT2A receptors in frontal cortex of healthy male volunteers was studied using [11C]-N-methyl spiperone ([11C]-NMSP) and positron emission tomography. Methods: The receptor occupancy percentage was assessed by the means of inhibition of [11C]-NMSP from the 5-HT2A receptors in the frontal cortex. Single oral doses of 20… Expand
Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone
Effect of the novel anxiolytic drug deramciclane on cytochrome P450 2D6 activity as measured by desipramine pharmacokinetics
Influence of food on the oral bioavailability of deramciclane from film-coated tablet in healthy male volunteers.
  • S. Drabant, K. Nemes, +8 authors I. Klebovich
  • Chemistry, Medicine
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2004
Brain receptor imaging.
  • W. Heiss, K. Herholz
  • Medicine
  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2006
Therapeutic potential of serotonin antagonists in depressive disorders
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease
...
1
2
...

References

SHOWING 1-10 OF 33 REFERENCES
D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
Serotonin receptors: Clinical implications
  • R. Glennon
  • Medicine, Biology
  • Neuroscience & Biobehavioral Reviews
  • 1990
...
1
2
3
4
...